Brands and Their Owners
Welcome to the Brand page for “GRAXOFIL”, which is offered here for Biosimilar pharmaceutical preparation, a granulocyte colony-stimulating factor analog used to stimulate the proliferation and differentiation of granulocytes for use with chemotherapy regimens to lessen the incidence of chemotherapy-induced neutropenia;.
Its status is currently believed to be active. Its class is unavailable. “GRAXOFIL” is believed to be currently owned by “ACCORD BIOPHARMA, INC.”
Owner: |
ACCORD BIOPHARMA, INC.
Owner Details |
---|---|
Description: |
Biosimilar pharmaceutical preparation, a granulocyte colony-stimulating factor analog used to stimulate the proliferation and differentiation of granulocytes for use with chemotherapy regimens to lessen the incidence of chemotherapy-induced neutropenia;
|
Categories: | BIOSIMILAR PHARMACEUTICAL PREPARATION |